- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01690793
Measurement of Natriuretic Hormone Peptides in Exacerbation of Asthma (acute asthma)
Study Overview
Status
Conditions
Detailed Description
Overall Study Design
- Measurement of Natriuretic Hormone Peptides in individuals suffering from exacerbation of asthma.
- Measurement of Natriuretic Hormone Peptides 5-7 days after initiation of treatment of exacerbation of asthma.
- Measurement of Natriuretic Hormone Peptides 10-14 days after initiation of treatment of exacerbation of asthma.
3 comparisons of Natriuretic Hormone Peptides levels will be made:
- Exacerbation compared to 5-7 days after initiation of treatment
- Exacerbation compared to 10-14 days after initiation of treatment
- 5-7 days after initiation of treatment compared to 10-14 days after initiation of treatment.
Samples of blood will be secured in the Division of Allergy/Immunology at the University of South Florida, Joy McCann Culverhouse Airways Disease Center. All samples will be appropriately coded to maintain confidentiality. Blood specimens will be held at minus 20 degrees Celsius.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Florida
-
Tampa, Florida, United States, 33613
- Usf Asthma Allergy and Immunology Cru
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
The Asthma Control Test score of less than 18.
Asthma control test consists of five questions, scored 1-5 each.
Description
Inclusion Criteria:
- Both genders, age 18-85.
- Females who are pregnant or lactating are not eligible.
- Read and comprehend English.
- Ability to give informed consent.
- Seen in the outpatient setting at one of the clinic.
- The subject must have a history of physician diagnosed asthma for at least 1 year and must have an exacerbation of asthma for entry into the study.
Study Plan
How is the study designed?
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
The measurement of NHPs after treatment of an exacerbation of asthma
Time Frame: 14 days
|
14 days
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- acute asthma
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on ASTHMA
-
Vanderbilt University Medical CenterNot yet recruitingAsthma in Children | Asthma Attack | Asthma Acute | Acute Asthma Exacerbation | Asthma; StatusUnited States
-
University of California, San FranciscoCompletedAsthma in Children | Asthma Attack | Asthma Acute | Asthma ChronicUnited States
-
SingHealth PolyclinicsNot yet recruitingAsthma | Asthma in Children | Asthma Attack | Asthma Acute | Asthma Chronic
-
Johann Wolfgang Goethe University HospitalCompleted
-
Universita di VeronaCompleted
-
Parc de Salut MarActive, not recruitingAsthma in Children | Persistent Asthma | Asthma ExacerbationSpain
-
Forest LaboratoriesCompleted
-
Brunel UniversityKarolinska InstitutetUnknown
-
Value Outcomes Ltd.AstraZenecaCompletedAsthma, Bronchial | Bronchial Asthma | Asthma Chronic | Asthma; EosinophilicCzechia